Tvardi Therapeutics, Incorporated
Nasdaq TVRD · Sugar Land, TX
Works in Dermatology · GI & liver · Oncology · Respiratory
Tvardi Therapeutics, Incorporated is a clinical trial sponsor based in Sugar Land, TX, listed as Nasdaq TVRD. It has 1 active clinical trial with 193 planned participants, in Dermatology, GI & liver, Oncology and Respiratory. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq TVRD
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Tvardi Therapeutics, Incorporated
Tvardi Therapeutics, Incorporated is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 193 planned participants, in Dermatology, GI & liver, Oncology, Respiratory. Since 2021 it has completed 2 trials and stopped 1 early.
Tvardi Therapeutics, Incorporated is based in Sugar Land, TX and is listed as Nasdaq TVRD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Tvardi Therapeutics, Incorporated; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-24.
Approve Suite is not affiliated with Tvardi Therapeutics, Incorporated.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.